Synergetic treatment of oxygen microcapsules and lenvatinib for enhanced therapy of HCC by alleviating hypoxia condition and activating anti-tumor immunity

[1]  Lei Dong,et al.  Visualizing nitric oxide-dependent HIF-1 activity under hypoxia with a lipid droplet-targeting fluorescent probe , 2021 .

[2]  M. Unno,et al.  The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors , 2021, Medical Oncology.

[3]  T. Liang,et al.  Nanoparticle-Stabilized Oxygen Microcapsules Prepared by Interfacial Polymerization for Enhanced Oxygen Delivery. , 2021, Angewandte Chemie.

[4]  M. Kharaziha,et al.  Polydopamine coated ZnO rod-shaped nanoparticles with noticeable biocompatibility, hemostatic and antibacterial activity , 2021 .

[5]  Y. Xin,et al.  Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy , 2021, Journal of Experimental & Clinical Cancer Research.

[6]  Margaret M. Billingsley,et al.  Nanomaterials for T-cell cancer immunotherapy , 2021, Nature Nanotechnology.

[7]  Yingchun Zhu,et al.  Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors. , 2020, Biomaterials.

[8]  Miaozun Zhang,et al.  Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma , 2020, Cell Death & Disease.

[9]  Martha Donoghue,et al.  FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma. , 2020, The oncologist.

[10]  Kazuhiro Yoshida,et al.  M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer , 2020, Scientific Reports.

[11]  D. Weitz,et al.  Diverse Particle Carriers Prepared by Co-Precipitation and Phase Separation: Formation and Applications. , 2020, ChemPlusChem.

[12]  Chenjing Yang,et al.  Biocompatible and pH-Responsive Colloidal Surfactants with Tunable Shape for Controlled Interfacial Curvature. , 2020, Angewandte Chemie.

[13]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[14]  Kai Yang,et al.  Radionuclide Imaging-Guided Chemo-Radioisotope Synergistic Therapy Using a 131I-Labeled Polydopamine Multifunctional Nanocarrier. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Qi Zhang,et al.  Hypoxia‐inducible factor‐1α/interleukin‐1β signaling enhances hepatoma epithelial–mesenchymal transition through macrophages in a hypoxic‐inflammatory microenvironment , 2018, Hepatology.

[16]  G. Farronato,et al.  Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders? , 2018, Journal of immunology research.

[17]  Yang Li,et al.  Correlation between Contrast-Enhanced Ultrasound and Microvessel Density via CD31 and CD34 in a rabbit VX2 lung peripheral tumor model. , 2017, Medical ultrasonography.

[18]  A. Harris,et al.  Advances in Hypoxia-Inducible Factor Biology. , 2017, Cell metabolism.

[19]  Shaker A. Mousa,et al.  The Role of Angiogenesis in Cancer Treatment , 2017, Biomedicines.

[20]  S. Påhlman,et al.  Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. , 2016, Pharmacology & therapeutics.

[21]  R. Phillips.  Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs , 2016, Cancer Chemotherapy and Pharmacology.

[22]  K. Shokat,et al.  Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. , 2011, Journal of hepatology.

[23]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[24]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[25]  R. Johnson,et al.  Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.

[26]  P. Zhao,et al.  Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules , 2021 .

[27]  D. Weitz,et al.  A general strategy for one-step fabrication of biocompatible microcapsules with controlled active release , 2020 .

[28]  Hirohisa Yano,et al.  Angiogenesis in Cancer , 2006, Vascular health and risk management.